Want to join the conversation?
Global pharmaceutical giant $ABBV today got the approval of VIEKIRAX from Japanese Ministry of Health, Labour and Welfare for the treatment of adult patients with HCV-1 infection, including those with compensated liver cirrhosis. With this approval, $ABBV is going to address the unmet need of approx. 2MM HCV patients in Japan.
I haven’t seen a drop in banks like this in a long time. Looks like $WFC is still facing pressures from its sales practices scandal..!!
Helping President-elect's America first focus, $WMT set to create 10,000 retail jobs in the US in 2017.
Looks like Trump has his eyes on the $MON and Bayer merger next. He had a meeting with the CEOs and apparently got job promises from them.